BioRestorative Therapies to provide clinical pipeline update on February 27

BioRestorative Therapies (BRTX) expects to provide a positive clinical pipeline update before market open on Thursday, February 27, 2025. “We very much look forward to updating investors on some recent meaningful key developments with respect to our clinical pipeline and review some additional positive events related to BRTX-100 on Thursday,” said Lance Alstodt, Chief Executive Officer of BioRestorative. “We are thrilled to be in a position that reflects the very solid work of our scientific team over the last several years come to fruition and excited to see that positive momentum continue.”